Literature DB >> 15674334

Tumor suppressor p53 represses transcription of RECQ4 helicase.

Sagar Sengupta1, Akira Shimamoto, Minori Koshiji, Remy Pedeux, Marek Rusin, Elisa A Spillare, Jiang Cheng Shen, L Eric Huang, Noralane M Lindor, Yasuhiro Furuichi, Curtis C Harris.   

Abstract

RECQ4 is a member of the RecQ helicase family, which has been implicated in the regulation of DNA replication, recombination and repair. p53 modulates the functions of RecQ helicases including BLM and WRN. In this study, we demonstrate that p53 can regulate the transcription of RECQ4. Using nontransformed, immortalized normal human fibroblasts, we show that p53-dependent downregulation of RECQ4 expression occurred in G1-arrested cells, both in the absence or presence of exogenous DNA damage. Wild-type p53 (but not the tumor-derived mutant forms) repressed RECQ4 promoter activity. The camptothecin or etoposide-dependent p53-mediated repression was attenuated by trichostatin A (TSA), an inhibitor of histone deacetylases (HDACs). Repression of the RECQ4 promoter was accompanied with an increased accumulation of HDAC1, and the loss of SP1 and p53 binding to the promoter. The simultaneous formation of a camptothecin-dependent p53-SP1 complex indicated its occurrence outside of the RECQ4 promoter. These data suggest that p53-mediated repression of RECQ4 transcription during DNA damage results from the modulation of the promoter occupancy of transcription activators and repressors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674334     DOI: 10.1038/sj.onc.1208380

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

Review 1.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells.

Authors:  Min Zhu; Robert S Weiss
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

3.  The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Authors:  Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathleen Hennessy; Gary L Rosner; Edwin Cook; M Eileen Dolan; Mark J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  2008-08-02       Impact factor: 3.333

4.  Human RecQL4 helicase plays critical roles in prostate carcinogenesis.

Authors:  Yanrong Su; Jarah A Meador; Gloria M Calaf; Luca Proietti De-Santis; Yongliang Zhao; Vilhelm A Bohr; Adayabalam S Balajee
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

5.  Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Authors:  Kensuke Kumamoto; Elisa A Spillare; Kaori Fujita; Izumi Horikawa; Taro Yamashita; Ettore Appella; Makoto Nagashima; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 6.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

Review 7.  Rothmund-Thomson syndrome.

Authors:  Lidia Larizza; Gaia Roversi; Ludovica Volpi
Journal:  Orphanet J Rare Dis       Date:  2010-01-29       Impact factor: 4.123

Review 8.  Protein methylation: a new mechanism of p53 tumor suppressor regulation.

Authors:  A Scoumanne; X Chen
Journal:  Histol Histopathol       Date:  2008-09       Impact factor: 2.303

Review 9.  Redox regulation of DNA repair: implications for human health and cancer therapeutic development.

Authors:  Meihua Luo; Hongzhen He; Mark R Kelley; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 10.  Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.

Authors:  Zdenko Herceg; Pierre Hainaut
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.